Neuberger Berman Group
XERS icon

Neuberger Berman Group’s Xeris Biopharma Holdings XERS Stock Holding History

Neuberger Berman Group’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$97K Buy
+16,725
New +$111K ﹤0.01% 2078
2018
Q3 		– Sell
-115,000
Closed -$2.18M – 1713
2018
Q2 		$2.18M Buy
+115,000
New +$2.23M ﹤0.01% 1047

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Neuberger Berman Group's XERS Position: Q1 2026 in Review

Neuberger Berman Group opened a new position in Xeris Biopharma Holdings (XERS) in Q1 2026: 16,725 shares worth $97K. The stake represents ﹤0.01% of the portfolio and ranks #2078 among its holdings. This is a return to the name: Neuberger Berman Group previously reported a position in XERS as recently as Q2 2018.

Neuberger Berman Group first reported a position in XERS in Q2 2018 and has held it in 2 quarters since. The position peaked at $2.18M in Q2 2018. 237 funds tracked by Wall St. Rank hold XERS as of Q1 2026.

  • Neuberger Berman Group held 16,725 shares of Xeris Biopharma Holdings worth $97K as of Q1 2026.
  • Xeris Biopharma Holdings was a new Neuberger Berman Group position in Q1 2026.
  • Xeris Biopharma Holdings made up ﹤0.01% of Neuberger Berman Group's portfolio in Q1 2026, its #2078 holding.
  • Neuberger Berman Group first reported a position in Xeris Biopharma Holdings in Q2 2018 and has held it in 2 quarters since.
  • Neuberger Berman Group's Xeris Biopharma Holdings position peaked at $2.18M in Q2 2018.
  • 237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2026.

Based on Neuberger Berman Group's 13F filing for Q1 2026, filed 14 May 2026.